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Summary
Induced pluripotency requires the expression of defined
factors and culture conditions that support the self-renewal
of embryonic stem (ES) cells [1]. Small molecule inhibition of
MAP kinase (MEK) and glycogen synthase kinase 3 (GSK3)
with LIF (2i/LIF) provides an optimal culture environment
for mouse ES cells [2] and promotes transition to naive plu-
ripotency in partially reprogrammed (pre-iPS) cells [3]. Here
we show that 2i/LIF treatment in clonal lines of pre-iPS cells
results in the activation of endogenous Nanog and rapid
downregulation of retroviral Oct4 expression. Nanog
enables somatic cell reprogramming in serum-free medium
supplemented with LIF, a culture condition which does not
support induced pluripotency or the self-renewal of ES cells,
and is sufficient to reprogram epiblast-derived stem cells to
naive pluripotency in serum-free medium alone. Nanog also
enhances reprogramming in cooperation with kinase inhibi-
tion or 5-aza-cytidine, a small molecule inhibitor of DNA
methylation. These results highlight the capacity of Nanog
to overcome multiple barriers to reprogramming and reveal
a synergy between Nanog and chemical inhibitors that
promote reprogramming. We conclude that Nanog induces
pluripotency in minimal conditions. This provides a strategy
for imposing naive pluripotency in mammalian cells inde-
pendently of species-specific culture requirements.
Results and Discussion
Investigating the Response to Kinase Inhibition in Clonal
Lines of Pre-iPS Cells
Pre-iPS cells have successfully acquired a proliferative
capacity but have not yet attained the transcriptional and
epigenetic hallmarks of naive pluripotency [3–5].To establish
clonal lines of pre-iPS cells, we first infectedmouse embryonic
fibroblasts (MEFs) and neural stem (NS) cells with retroviral
transgenes. We then picked and expanded individual pre-iPS
cell colonies in serum/LIF conditions. Transfer and passaging
in serum-free 2i/LIF medium generated a culture of iPS cells
with uniform Oct4-GFP reporter activity (Figure 1A) and the
capacity to contribute to adult mice (see Figure S1A available
online).Weak activity of theOct4 reporter was detected in <2%*Correspondence: jcs64@cscr.cam.ac.uk
3Present address: Cancer Research UK Paterson Institute, The University
of Manchester, Manchester M20 4BX, UKof pre-iPS cells in serum/LIF conditions (Figure 1A). Individual
GFP events in pre-iPS cells, however, were significantly less
intense than in iPS cells obtained from the same clones in
2i/LIF. To clarify the identity of the subset of pre-iPS cells
with weak Oct4-GFP reporter activity, we performed serial
purification of GFP-positive pre-iPS cells to obtain sufficient
amounts of pure material for transcriptional and epigenetic
characterization (Figure S1B). Retroviral transgene expression
was maintained in GFP-positive pre-iPS cells, but fully
silenced in 2i-iPS cells derived from the same clonal lines (Fig-
ure S1C). GFP-positive pre-iPS cells expressed Fgf4 and
Nr0b1, which are recurrently detected in partially reprog-
rammed cells [3, 4]. However, other markers of authentic plu-
ripotency such as Nanog and Rex1 remained undetectable in
these cells. The Nanog promoter region was methylated in
a pure sample of GFP-positive pre-iPS cells, but completely
demethylated in 2i-iPS cells (Figure S1D). These results
demonstrate that weak Oct4-GFP activity in clonal lines of
pre-iPS cells in serum/LIF is not a sign of complete reprogram-
ming. Consequently, 2i treatment does not select for expan-
sion of an already resident pluripotent subpopulation, but
actively induces conversion to pluripotency in pre-iPS cells.
To investigate the transcriptional response to 2i/LIF treat-
ment in pre-iPS cells, we plated pre-iPS cells at clonal density
on a feeder layer in serum/LIF until emergence of macroscopic
colonies, at which point medium was switched to 2i/LIF. Oct4-
GFP reporter activity was monitored at daily time points and
samples were collected for gene expression analysis. Surpris-
ingly, weak Oct4-GFP reporter activity initially disappeared
completely upon switch to 2i/LIF (Figure 1B). This further indi-
cates that sporadic Oct4-GFP reporter activity in serum/LIF
reflects transient activation of the Oct4 promoter and is not
a sign of pluripotency (Figures S1C and S1D). By day 6 of
2i/LIF treatment, stable Oct4-GFP reporter activity began to
appear in multiple colonies. The proportion of GFP-positive
cells increased to approximately 30% by day 10. 2i treatment
was accompanied by a degree of cell death, which became
apparent 3 days after the medium switch (Figure 1B). Phos-
pho-Erk (p-Erk) signal was completely extinguished within
24 hr of inhibitor treatment (Figure 1C). Fgf4 and Nr0b1 expres-
sion was initially downregulated upon switch to 2i/LIF, but
reappeared during later time points together with other pluri-
potency markers (Figure 1D). In contrast, we observed a 30-
fold upregulation of Nanog expression within 48 hr after
switching to 2i/LIF (Figure 1E). Expression of Nanog increased
steadily in subsequent time points. Unlike the initial reduction
seen in pre-iPS cells, the same transcripts changed little in ES
cells transferred from serum/LIF to 2i/LIF (Figures S1E–S1G).
This confirms that the observed expression patterns are
specific to pre-iPS cells as they reprogram.
In agreement with a recent study [6], we found that total
expression of Oct4 and Klf4 was considerably higher in retro-
virally derived pre-iPS cells than in ES cells (Figure S1H).
However, we observed a reduction in retroviral transgene
expression upon 2i/LIF treatment in pre-iPS cells (Figure 1F).
Oct4 protein expression was 4 to 5-fold higher in pre-iPS cells
compared with iPS cells and was significantly downregulated
in pre-iPS cells 2 days after switching to 2i/LIF (Figures 1G and
Figure 1. Characterization of the Response to Kinase Inhibition in Clonal Lines of Pre-iPS Cells
(A) Top: phase and Oct4-GFP images of MEF-OKMS clone 1 and NS-OKM clone 1 pre-iPS cells cultured on a MEF feeder layer in serum/LIF conditions, and
iPS cells derived in 2i/LIF from the same clonal lines. Bottom: flow cytometry analysis indicates the proportion of cells with Oct4-GFP reporter activity.
OKMS and OKM refer to combinations of retroviral Oct4, Klf4, c-Myc, and Sox2 transgenes.
(B) Experimental system for assessing transcriptional dynamics in clonal lines of pre-iPS cells during switch from serum/LIF to 2i/LIF conditions. Flow
cytometry diagrams indicate the proportion of cells positive for the Oct4-GFP reporter transgene, and the proportion of live cells at daily time points during
2i/LIF treatment of pre-iPS cells (MEF-OKMS clone 1). Inlaid percentages in cell viability charts indicate the proportion of DAPI-negative (live) cells at each
time point.
(C) Western blot analysis for p-Erk1/2 and total Erk1/2 protein expression in pre-iPS cells cultured for 1 day in 2i/LIF medium.
(D) Time course qRT-PCR analysis of endogenous pluripotency genes Fgf4, Nr0b1, and Rex1 during switch from serum/LIF (d0) to 2i/LIF conditions in pre-
iPS cells. Error bars indicate the range of fold change relative to the day 10 sample.
(E) Time course qRT-PCR analysis of Nanog expression after switching pre-iPS cells from serum/LIF to 2i/LIF conditions. Relative expression is shown on
a logarithmic scale. Error bars indicate the range of fold change relative to the day 0 sample.
(F) Time course qRT-PCR analysis of retroviral transgene expression during switch from serum/LIF (d0) to 2i/LIF conditions in pre-iPS cells. Error bars indi-
cate the range of fold change relative to the day 0 sample.
(G) Western blot analysis for Oct4 protein expression in pre-iPS cells cultured in serum/LIF or for 2 days in 2i/LIF and 2i-iPS cells.
(H) Infra-red quantification of Oct4 protein intensity relative to a-tubulin in the samples shown in (G). Error bars indicate SD from analysis of two gels.
(I) Time course flow cytometry analysis of changes in Oct4-GFP reporter activity during switch of pre-iPS cells plated in serum/LIF to serum-free 2i/LIF or
serum-free medium supplemented with LIF, 2i, the GSK3 inhibitor (CHIR99021) and LIF or the MEK inhibitor (PD0325901) and LIF. See also Figure S1.
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671H; FigureS1I). This reduction inOct4 expressionwas a combi-
natorial effect of the kinase inhibitors rather than serum deple-
tion (Figures S1J–S1L). A modest increase in Oct4 expression
is known to induce a differentiation program in ES cells [7]. We
investigated the effect of further increases in Oct4 expression
by stably transfecting a tamoxifen-inducible Oct4 vector in ES
cells (Figure S1M) [8]. Induction of Oct4-ires-GFP occurred
rapidly and by 48 hrw80% of cells were GFP-positive in two
independent clones (Figure S1N). Oct4 overexpression
induced an acute reduction in Nanog and Sox2 expression,
which preceded modest induction of the differentiation
markers Brachyury and Gata6 (Figures S1O and S1P). We infer
that the levels of Oct4 observed in pre-iPS cells present an
impediment to pluripotency gene expression.
We asked which component in 2i/LIF medium was respon-
sible for the induction of pluripotency in pre-iPS cells. Switch-
ing to serum-free medium with LIF alone did not give rise to
stable Oct4-GFP reporter activity (Figure 1I). Treatment with
2i in absence of LIF slowed the appearance of Oct4-GFP
reporter activity compared with the 2i/LIF control induction,
but reprogramming efficiency was still robust. A small number
(0.1%) of strong Oct4-GFP events emerged after treating pre-
iPS cells with the GSK3 inhibitor and LIF. Application of the
MEK inhibitor and LIF, however, induced robust Oct4 reporter
activity in up to 43% of cells by day 12. This was also the most
selective culture medium we tested, with less than 40% cell
viability after just 4 days of treatment. These data indicate
that MEK inhibition is the main reprogramming cue in 2i and
also exerts selection against pre-iPS cells.Nanog Enhances Reprogramming in Cooperation
with 2i or Inhibition of DNA Methylation
Nanogwas activated early in response to 2i/LIF treatment (Fig-
ure 1E) and occupies a central position in the transcriptional
network regulating pluripotency [9, 10]. Using a loss-of-func-
tion approach we previously demonstrated that Nanog is
necessary for the formation of embryonic and induced pluripo-
tency [11]. In addition, Nanog was reported to accelerate
reprogramming in a study using inducible lentiviral transgenes
[12]. Here, we asked whether forced expression of Nanog
might be sufficient to overcome the reprogramming block in
pre-iPS cells. We made use of PiggyBac (PB) transposition
[13] to introduce a transgene driving Nanog expression under
control of a CAG promoter (PB-Nanog) in a clonal line of MEF-
derived pre-iPS cells. Control transfectants expressing an
empty vector transgene (PB-Empty) were generated in
parallel. Expression of Nanog in stable transfectants
expanded in serum/LIF was 1.5-fold higher compared with
iPS cells. Forced expression of Nanog did not result in activa-
tion of the pluripotency marker Rex1 or downregulation of
retroviral expression (Figure 2A). Lack of Oct4-GFP reporter
activity further demonstrates that Nanog could not overcome
the block to full reprogramming in presence of serum (Fig-
ure 2B). Oct4 promoter methylation persisted in PB-Nanog
pre-iPS cells (Figure 2C). In contrast, the percentage of meth-
ylated CpG sites in theOct4 distal enhancer was reduced from
38% in PB-Empty pre-iPS cells to 8% in PB-Nanog pre-iPS
cells (Figure 2C). The distal enhancer is responsible for driving
Oct4 expression in preimplantation embryos and ES cells [14]
and contains the CR4 element, a critical binding site of Nanog
in ES cells [15]. Chromatin immunoprecipitation analysis sug-
gested that reduced CpGmethylation might correlate with low
level Nanog occupancy of the CR4 element in PB-Nanog pre-iPS cells (Figure 2D). However, Nanog occupancy was signifi-
cantly higher in iPS cells.
Since the Oct4 promoter remained hypermethylated in PB-
Nanog pre-iPS cells, we asked whether chemical inhibition of
DNA methylation could promote reprogramming to pluripo-
tency. Indeed, treatment with the DNA methyltransferase
inhibitor 5-aza-cytidine (AZA) for 10 days generated a signifi-
cant proportion of cells with stable Oct4-GFP reporter activity
in serum/LIF (Figure 2E). A small number of GFP-positive cells
also emerged upon AZA treatment in PB-Empty or wild-type
pre-iPS cells (Figure 2E; Figures S2A and S2B). Purification
and subcloning of these GFP-positive cells generated a line
of homogeneous iPS cells capable of contribution to chimeric
mice (Figures S2C–S2E). This confirms a previous report that
global inhibition of DNA methylation promotes direct reprog-
ramming [4]. The de novo methyltransferase Dnmt3a was ex-
pressed in pre-iPS cells throughout 2i/LIF induction, while
Dnmt3b expression was initially reduced and then upregulated
(Figure S2F). Immunofluorescence analysis for Dnmt3b during
2i/LIF treatment showed weak cytoplasmic staining in pre-iPS
cells and a stronger nuclear signal in iPS cells positive for both
Oct4-GFP and Nanog protein (Figure S2G). This pattern shows
resemblance to primordial germ cells where Dnmt3b is
excluded from the nucleus at the time of DNA demethylation
and epigenetic reprogramming [16]. The significant increase
in efficiency of AZA-induced reprogramming in the PB-Nanog
background reveals a synergy between Nanog and inhibition
of global DNA methylation. We also examined reprogramming
kinetics upon the application of 2i/LIF medium in PB-Nanog
and PB-Empty pre-iPS cells. When transferred to 2i/LIF
Oct4-GFP activity appeared earlier and the proportion of posi-
tive cells was more than 10-fold higher in the constitutive
Nanog background (Figure 2E).
These results show that Nanog cooperates with distinct
small molecules to enhance the efficiency of direct reprogram-
ming. These pathways also intersect since endogenous Nanog
was activated in response to 2i/LIF treatment in pre-iPS cells
(Figure 1E), and suppression of p-Erk signaling results in
increased Nanog expression in ES cells [17, 18]. Further gains
in reprogramming yield may be obtained by integrating other
chemical strategies that complement or reinforce the effects
of these inhibitors. TGF-beta inhibition was reported to induce
endogenous Nanog expression in partially reprogrammed
cells but did not affect the kinase targets of the 2i cocktail
[19]. Vitamin C treatment also promoted reprogramming in
a MEK-independent manner and resulted in demethylation of
the Nanog promoter [20]. This suggests that chemicals that
promote or enhance the efficiency of reprogramming may
converge on common transcriptional targets.
Nanog Promotes Somatic Cell Reprogramming
in Serum-Free Medium with LIF
We then considered whether constitutive expression of Nanog
might be sufficient to promote transition to pluripotency in
serum-free conditions. No stable Oct4-GFP reporter activity
was observed after switching PB-Nanog pre-iPS cells to
serum-free medium alone. However, the Oct4-GFP reporter
was robustly induced in presence of LIF (Figures 3A and 3B).
PB-Empty pre-iPS cells did not give rise to stable GFP-ex-
pressing cells in either condition. GFP-positive cells that
emerged in the constitutive Nanog background expressed
Rex1, Klf2, and endogenous Oct4 and fully silenced retroviral
transgenes (Figure 3C). To confirm this result in a different
somatic origin, we introduced a PB-Nanog transgene in adult
Figure 2. Nanog Enhances Reprogramming in Synergy with 2i or Inhibition of DNA Methylation
(A) A piggyBac (PB) transgene was used to generate stable Nanog expressing cells in a clonal line of pre-iPS cells (MEF-OKMS clone 1). qRT-PCR analysis
comparing expression of Nanog, Rex1, retroviral (r) Oct4 and r-Klf4 in PB-Nanog and PB-Empty pre-iPS cells expanded in serum/LIF. Error bars indicate the
range of fold change relative to the sample with highest expression.
(B) Flow cytometry analysis indicates the proportion of cells with Oct4-GFP reporter activity in both transgenic backgrounds in serum/LIF.
(C) Bisulfite sequencing analysis of DNAmethylation in theOct4 distal enhancer and promoter in PB-Empty and PB-Nanog pre-iPS cells and 2i-iPS cells. The
percentage of methylated CpG sites is indicated above each methylation panel.
(D) Chromatin immunoprecipitation analysis with a native Nanog antibody to the CR4 element in the Oct4 distal enhancer and a gene desert control region.
Results of two independent experiments are shown. iPS cell occupancy was not measured in experiment A. Occupancy is plotted as fold enrichment over
IgG after normalization to the input, and error bars represent standard deviation of the technical replicates of the qPCR for each experiment.
(E) Flow cytometry analysis comparing Oct4-GFP reporter activity after treatment of PB-Nanog and PB-Empty pre-iPS cells with 2i/LIF in serum-free
medium or AZA (3 mM) in presence of serum/LIF. See also Figure S2.
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switched after 5 days to serum-freemediumwith LIF or serum-
free medium alone. Stable Oct4-GFP activity emerged in
multiple colonies in serum-free medium with LIF within
7 days (Figure S3B). TheseGFP-positive cells had a pluripotent
gene expression profile (Figure S3C). Since constitutive Nanog
expression is likely to interfere with embryonic development,
we opted to assess developmental potential 52 hr after morula
aggregation, which corresponds to a late blastocyst stage.
PB-Nanog iPS cells derived in serum-free medium with LIF
readily colonized the epiblast and maintained homogeneous
Oct4 reporter activity (Figure 3D; Figure S3D). In contrast,
postimplantation epiblast-derived stem cells (EpiSCs) incor-
porated in the epiblast but Oct4-GFP reporter activity was
greatly reduced 52 hr after aggregation.These results demonstrate that constitutive expression of
Nanog promotes transition to pluripotency in serum-free
medium with LIF. The requirement of LIF for Nanog-induced
reprogramming provides evidence that kinase inhibition has
additional targets, since 2i was sufficient to convert pre-iPS
cells to pluripotency in absence of LIF (Figure 1I). p-Erk levels
were sustained in serum-free medium with LIF (Figure 3E). We
also found that high Oct4 levels were unaffected after switch-
ing pre-iPS cells to serum-free medium with LIF (Figures S1J
and S1K). Thus, Nanog can overcome the adverse effects of
both p-Erk and high levels of Oct4 expression during reprog-
ramming.We tested whether constitutive expression of Nanog
can counteract the effects of Oct4 elevation in ES cells [7].
Expression of an episomal Oct4 transgene in ES cells caused
pronounced differentiation by morphological criteria and the
Figure 3. Nanog Promotes Somatic Cell Reprogramming in Minimal Conditions
(A) Flow cytometry analysis of Oct4-GFP reporter activity in PB-Empty and PB-Nanog pre-iPS cells cultured for 2weeks in serum-freemediumor serum-free
medium with LIF.
(B) Phase and Oct4-GFP images of PB-Empty and PB-Nanog pre-iPS cells cultured for 2 weeks in serum-free medium or serum-free medium with LIF.
(C) qRT-PCR analysis for endogenous pluripotency genes and retroviral transgenes in iPS cells derived from PB-Nanog pre-iPS cells in serum-free medium
with LIF. Error bars indicate the range of fold change relative to PB-Nanog pre-iPS cells.
(D) Oct4-GFP reporter activity in blastocysts 52 hr after morula aggregation of PB-Nanog iPS cells derived in serum-free medium with LIF.
(E) Western blot analysis for p-Erk1/2 and total Erk1/2 protein expression in PB-Nanog and PB-Empty pre-iPS cells cultured for 1 day in serum/LIF with the
MEK inhibitor PD0325901 or serum-free medium supplemented with LIF alone. See also Figure S3.
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69lack of alkaline phosphatase activity (Figures S3E and S3F).
In contrast, self-renewal and expression of pluripotency genes
were maintained upon coexpression of Oct4 and Nanog trans-
genes (Figures S3E–S3G). This indicates that Nanog safe-
guards establishment and maintenance of pluripotency
against the effects of high levels of Oct4.
Nanog Is Sufficient to Reprogram Epiblast-Derived Stem
Cells to Naive Pluripotency
Finally, we asked whether Nanog is sufficient to mediate
reprogramming in absence of both exogenous self-renewing
factors and other reprogramming transgenes. For this purpose
we introduced a PB-Nanog transgene in EpiSCs, which can be
reprogrammed to naive pluripotency by transfection with
defined factors and culture in 2i/LIF [11, 13, 21]. Stable PB-
Nanog transfectants were transferred to serum-free medium
with or without LIF (Figure 4A). Under these conditions, PB-
Nanog EpiSCs gave rise to putative iPS cell colonies (Epi-iPS)
that were resistant to puromycin selection for theOct4 reporter
transgene in both conditions (Figure 4B). Establishment of
naive pluripotency was confirmed by upregulation of ES-cell
specific transcripts, and downregulation of EpiSC markers
(Figures 4C and 4D). However, expression of Klf4 and Klf2 fell
short of ES cell levels after transfer to serum-free medium
alone. The silent X chromosome was epigenetically reprog-
rammed, but me3H3K27 foci were detected in 28% of cells
after transfer to serum-free medium alone (Figure 4E). We
then examined the response of PB-Nanog Epi-iPS cells to 2i
treatment. This caused rapid downregulation of the Oct4-
GFP reporter and progressive cell death in parental EpiSCs(Figure 4F). In contrast, PB-Nanog Epi-iPS cells obtained in
both serum-free medium with LIF and serum-free medium
alone maintained homogeneous Oct4-GFP reporter activity
after 2i treatment (Figure 4F). To ascertain acquisition of bona
fide pluripotency, we performed morula aggregations (Fig-
ure 4G). PB-Nanog Epi-iPS cells incorporated in the epiblast
andmaintainedOct4 reporter activity.Weconclude thatNanog
directs EpiSCs to naive pluripotency in conditions free of
known exogenous self-renewing factors. p-Erk levels were
sustained in these culture conditions (Figure 4H). The finding
that LIF is dispensable for Nanog-induced reprogramming in
EpiSCs but not somatic cells may reflect the fact that EpiSCs
and ES cells already share expression of a significant number
of pluripotency regulators [22, 23]. However, our data also indi-
cate that LIF/STAT3 signaling stabilizes Epi-iPS cells transcrip-
tionally and epigenetically. This is in agreement with the recent
finding that activation of STAT3 is limiting during reprogram-
ming of somatic cells and EpiSCs [24].
In this study, we investigated limiting components during
the final stages of direct reprogramming. We found that Nanog
has the capacity to overcome p-Erk signaling and high levels
of Oct4 and enable reprogramming in minimal conditions.
This result is significant in light of recent interest to generate
a naive pluripotent state in cells of non-rodent origin, including
human [25–27]. Conventional human ES cell culture conditions
induce differentiation in naive pluripotent mouse cells [13].
By identifying factors such as Nanog that enable reprogram-
ming in minimal conditions, it may be possible to bypass
species-specific culture requirements and establish naive plu-
ripotency in other mammalian species.
Figure 4. Nanog Is Sufficient to Reprogram Epiblast-Derived Stem Cells to Naive Pluripotency
(A) Strategy for examining the sufficiency of Nanog in reprogramming of epiblast-derived stem cells (EpiSCs). A piggyBac (PB) Nanog-dsRed transgene was
used to generate constitutive Nanog expressing EpiSCs, which also contain an Oct4-GFP reporter transgene. After selection in EpiSC culture conditions,
PB-Nanog-dsRed EpiSCs were cultured in serum-free medium with LIF or serum-free medium alone.
(B) Phase and Oct4-GFP images of emerging Epi-iPS colonies that were resistant to puromycin selection for the Oct4 reporter transgene.
(C) qRT-PCR analysis of PB-Nanog EpiSCs in Fgf2 and Activin (F+A) and passage 1 PB-Nanog transfectants in serum-free medium with LIF. Error bars indi-
cate the range of fold change relative to the sample with highest expression.
(D) qRT-PCR analysis of PB-Nanog Epi-iPS cells derived in serum-free medium alone. Error bars indicate the range of fold change relative to wild-type
EpiSCs.
(E) Immunostaining for me3H3K27 of PB-Nanog EpiSCs cultured in Fgf2 and Activin, and PB-Nanog Epi-iPS cells derived in serum-free medium with LIF or
serum-free medium alone.
(F) Time course flow cytometry analysis of Oct4-GFP reporter activity after transferring wild-type (WT) EpiSCs and PB-Nanog Epi-iPS cells that were derived
in serum-free medium or serum-free medium with LIF to 2i/LIF.
(G) Fluorescence images showing Oct4-GFP reporter activity in blastocysts 52 hr after morula aggregation of PB-Nanog Epi-iPS cells derived in serum-free
medium with LIF and serum-free medium alone.
(H) Western blot analysis for p-Erk1/2 and total Erk1/2 protein expression in PB-Nanog-EpiSCs cultured in Fgf2 and Activin or for 1 day in 2i/LIF, LIF or
serum-free medium alone.
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Pre-iPS cells were obtained by retroviral infection of NS cells or MEFs with
pMXs-based retroviral reprogramming factors [1, 3]. Cultures were changed
into ES cell medium (serum/LIF) at day 3 posttransduction. For furtherexpansion, pre-iPS cells were replated onto feeders at day 5 in serum/LIF.
Pre-iPS and NS cells were transfected using nucleofection (Amaxa) with
1 mg of PB-flox-Nanog-Pgk-Hygro plus 2 mg PBase expression vector,
pCAGPBase [11]. For time course real-time PCR analysis of iPS cell induc-
tion, pre-iPS cells were plated in serum/LIF at clonal density on a STO or
Nanog Induces Pluripotency in Minimal Conditions
71DsRed-expressing fibroblast feeder layer in 10 cm (3000 pre-iPS cells
plated) or 6W (600 pre-iPS cells plated) format. Medium was switched to
2i/LIF when colonies reached macroscopic colony density after 6–8 days.
Samples were collected daily for RNA extraction, either directly from whole
pellets or after flow cytometric elimination of DsRed-expressing feeders. By
time pre-iPS cell colonies had reached macroscopic density, feeders
comprised no more than 2% of the complete culture. PB-Nanog iPS cells
were at a proliferative disadvantage compared with pre-iPS cells in
serum-free medium with LIF, requiring flow cytometric purification of cells
positive for the Oct4-GFP reporter.
Supplemental Information
Supplemental Information includes three figures, Supplemental Experi-
mental Procedures, and one table and can be found with this article online
at doi:10.1016/j.cub.2010.11.074.
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